Synaptogenix, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 6.04 million compared to USD 5.57 million a year ago. Basic loss per share from continuing operations was USD 29.5 compared to USD 20.25 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.452 USD | -1.72% | +2.11% | -34.51% |
Apr. 09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
Apr. 03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
1st Jan change | Capi. | |
---|---|---|
-34.51% | 4.92M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- SNPX Stock
- News Synaptogenix, Inc.
- Synaptogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023